Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin J Lee

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Ejhaem|January 30, 2026
Acute Myeloid Leukemia With Plasmacytoid Differentiating Cutaneous Lesions: A Case of Double Identity or Active TransformationBenjamin J Lee, Shawn P Griffin, Deepa Jeyakumar, et al.
The Annals of Pharmacotherapy|June 9, 2020
Treatment Considerations for CNS Infections Caused by Vancomycin-Resistant <i>Enterococcus faecium</i>: A Focused Review of Linezolid and DaptomycinBenjamin J Lee, Betty N Vu, Amanda N Seddon, et al.
BMC Cancer|June 19, 2026
Real-world evidence for the impact of circadian clock on the benefit from immune checkpoint inhibitors in solid tumorsEli M Soyfer, Benjamin J Lee, Abraham J Qavi, et al.
Annals of Hematology|October 22, 2024
Intensification of upfront chemotherapy for patients with myeloid blast phase CML: a single center experienceBenjamin J Lee, Shawn P Griffin, Jean Doh, et al.
Current Pain and Headache Reports|September 10, 2022
Platelet-Rich Plasma Injections: Pharmacological and Clinical Considerations in Pain ManagementAudrey A Grossen, Benjamin J Lee, Helen H Shi, et al.
Cancer Medicine|October 12, 2024
Upfront Management of Blastoid Variant Mantle Cell Lymphoma: Making the Case for 2nd/3rd-Generation Bruton Tyrosine Kinase Inhibitor-Based TherapiesBenjamin J Lee, Jenny Liu, Shawn P Griffin, et al.
Cardio-Oncology (London, England)|April 28, 2025
Time dependent predictors of cardiac inflammatory adverse events in cancer patients receiving immune checkpoint inhibitorsMichael Sayer, Hirofumi Hamano, Misako Nagasaka, et al.
Transplantation Direct|August 11, 2017
Refining the Policy for Timing of Kidney Transplant Waitlist QualificationBenjamin J Lee, Charles E McCulloch, Barbara A Grimes, et al.
European Journal of Haematology|April 22, 2023
Impact of triple intrathecal prophylaxis in acute lymphoblastic leukemia adults receiving HyperCVAD: A COVID-19 practice changeBenjamin J Lee, Piyanuch Kongtim, Jean Doh, et al.
Ejhaem|April 29, 2025
Balancing the Risk of Cardiotoxicity Outcomes in Treatment Selection for Multiple Myeloma: A Retrospective Multicenter Evaluation of Ixazomib, Lenalidomide, and Dexamethasone (IRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (KRd)Benjamin J Lee, Michael Sayer, Ali A Naqvi, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Ejhaem|January 30, 2026
Acute Myeloid Leukemia With Plasmacytoid Differentiating Cutaneous Lesions: A Case of Double Identity or Active TransformationBenjamin J Lee, Shawn P Griffin, Deepa Jeyakumar, et al.
The Annals of Pharmacotherapy|June 9, 2020
Treatment Considerations for CNS Infections Caused by Vancomycin-Resistant <i>Enterococcus faecium</i>: A Focused Review of Linezolid and DaptomycinBenjamin J Lee, Betty N Vu, Amanda N Seddon, et al.
BMC Cancer|June 19, 2026
Real-world evidence for the impact of circadian clock on the benefit from immune checkpoint inhibitors in solid tumorsEli M Soyfer, Benjamin J Lee, Abraham J Qavi, et al.
Annals of Hematology|October 22, 2024
Intensification of upfront chemotherapy for patients with myeloid blast phase CML: a single center experienceBenjamin J Lee, Shawn P Griffin, Jean Doh, et al.
Current Pain and Headache Reports|September 10, 2022
Platelet-Rich Plasma Injections: Pharmacological and Clinical Considerations in Pain ManagementAudrey A Grossen, Benjamin J Lee, Helen H Shi, et al.
Cancer Medicine|October 12, 2024
Upfront Management of Blastoid Variant Mantle Cell Lymphoma: Making the Case for 2nd/3rd-Generation Bruton Tyrosine Kinase Inhibitor-Based TherapiesBenjamin J Lee, Jenny Liu, Shawn P Griffin, et al.
Cardio-Oncology (London, England)|April 28, 2025
Time dependent predictors of cardiac inflammatory adverse events in cancer patients receiving immune checkpoint inhibitorsMichael Sayer, Hirofumi Hamano, Misako Nagasaka, et al.
Transplantation Direct|August 11, 2017
Refining the Policy for Timing of Kidney Transplant Waitlist QualificationBenjamin J Lee, Charles E McCulloch, Barbara A Grimes, et al.
European Journal of Haematology|April 22, 2023
Impact of triple intrathecal prophylaxis in acute lymphoblastic leukemia adults receiving HyperCVAD: A COVID-19 practice changeBenjamin J Lee, Piyanuch Kongtim, Jean Doh, et al.
Ejhaem|April 29, 2025
Balancing the Risk of Cardiotoxicity Outcomes in Treatment Selection for Multiple Myeloma: A Retrospective Multicenter Evaluation of Ixazomib, Lenalidomide, and Dexamethasone (IRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (KRd)Benjamin J Lee, Michael Sayer, Ali A Naqvi, et al.
Pageof 6